Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1900 of 3546 entries
View as:

Comparison of Immunogenicity and Reactogenicity of INFANRIX™ HEXA and HEXAVAC™ Vaccines as a Primary Vaccination Course

Phase: N/A Priority: Normal
NCT ID: NCT01457547 Org: User:
Start: 10/31/03 End: 05/31/05 Due: 05/31/06

Dose-escalation Study of GSK2330672 in Japanese Healthy Male Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT02801981 Org: User:
Start: 06/30/16 End: 08/31/16 Due: 08/31/17

Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03189589 Org: User:
Start: 06/15/17 End: 07/24/17 Due: 07/24/18

A Randomized Study To Evaluate The Efficacy And Safety Of An Investigational Drug In Adolescent And Adult Subjects With Persistent Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT00398645 Org: User:
Start: 11/15/06 End: 08/30/07 Due: 08/30/08

An Exploratory Study on the Effects of Repeat Doses of Albiglutide Compared to Exenatide on Gastric Myoelectrical Activity and Gastric Emptying in Type 2 Diabetes Mellitus Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02793154 Org: User:
Start: 09/26/16 End: 03/16/17 Due: 03/16/18

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine With Various Formulations in Adults >= 50 Years

Phase: N/A Priority: Normal
NCT ID: NCT00802464 Org: User:
Start: 01/12/09 End: 07/02/10 Due: 07/02/11

Study Of Safety And Tolerability Of GW786034 Given With Lapatinib In Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00158782 Org: User:
Start: 09/28/04 End: 08/21/07 Due: 08/21/08

Immuno Positron Emission Tomography Study of GSK2849330 in Subjects With Human Epidermal Growth Factor Receptor 3-Positive Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02345174 Org: User:
Start: 03/19/15 End: 06/02/16 Due: 06/02/17

Clinical Study Of Schizophrenia in Both Men and Women

Phase: N/A Priority: Normal
NCT ID: NCT00071747 Org: User:
Start: 08/31/03 End: 01/31/05 Due: 01/31/06

A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Phase: N/A Priority: Normal
NCT ID: NCT03527173 Org: User:
Start: 08/29/18 End: 11/11/19 Due: 11/11/20

Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With Placebo

Phase: N/A Priority: Normal
NCT ID: NCT00824356 Org: User:
Start: 06/30/08 End: 08/31/08 Due: 08/31/09

To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01808339 Org: User:
Start: 03/31/13 End: 03/31/14 Due: 03/31/15

A Study to Investigate the Effect of SB-705498 on Chronic Cough

Phase: N/A Priority: Normal
NCT ID: NCT01476098 Org: User:
Start: 04/30/11 End: 01/31/12 Due: 01/31/13

LENS - Long-term Eltrombopag Observational Study

Phase: N/A Priority: Normal
NCT ID: NCT00643929 Org: User:
Start: 02/28/07 End: 03/31/13 Due: 03/31/14

To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01751074 Org: User:
Start: 12/17/12 End: 03/14/13 Due: 03/14/14

Safety and Efficacy Dose of Artesunate Used in Combination With LAPDAP Treatment of Uncomplicated Falciparum Malaria

Phase: N/A Priority: Normal
NCT ID: NCT00519467 Org: User:
Start: 06/30/03 End: 02/28/05 Due: 02/28/06

Randomized Placebo Controlled Efficacy And Safety Study Investigating GW876008 In Patients With Irritable Bowel Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00421707 Org: User:
Start: 10/14/06 End: 06/25/08 Due: 06/25/09

Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00657657 Org: User:
Start: 04/30/08 End: 08/31/08 Due: 08/31/09

RLS In Adults: Comparing Immediate Release Formulation With Extended Release Formulation Of Ropinirole

Phase: N/A Priority: Normal
NCT ID: NCT00314860 Org: User:
Start: 02/28/06 End: 12/31/06 Due: 12/31/07

Effects of GSK1278863A on Pulmonary Artery Pressure in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01673555 Org: User:
Start: 05/15/12 End: 11/19/12 Due: 11/19/13

Study of Safety, Blood Levels and Brain Receptor Occupancy of GSK598809 Using PET Imaging in Health Males.

Phase: N/A Priority: Normal
NCT ID: NCT00468806 Org: User:
Start: 04/30/07 End: 05/31/08 Due: 05/31/09

Clinical Evaluation of Ropinirole PR/XR Tablets in Monotherapy for Parkinson's Disease (PD)

Phase: N/A Priority: Normal
NCT ID: NCT00434304 Org: User:
Start: 04/09/07 End: 03/10/09 Due: 03/10/10

COREG MR Versus TOPROL-XL On Reduction Of Microalbuminuria In Patients With Hypertension And Microalbuminuria

Phase: N/A Priority: Normal
NCT ID: NCT00123903 Org: User:
Start: 07/31/05 End: 05/31/06 Due: 05/31/07

The Expression of Antigens in Bone Marrow Samples From Volunteering Donors.

Phase: N/A Priority: Normal
NCT ID: NCT00706199 Org: User:
Start: 07/03/08 End: 01/23/09 Due: 01/23/10

Examining the Effect of Different Diuretics on Fluid Retention in Diabetics Treated With Rosiglitazone.

Phase: N/A Priority: Normal
NCT ID: NCT00306696 Org: User:
Start: 10/31/02 End: 01/31/04 Due: 01/31/05